VRCA
Verrica Pharmaceuticals Inc

2,353
Mkt Cap
$78.28M
Volume
89,032.00
52W High
$9.82
52W Low
$3.28
PE Ratio
-2.39
VRCA Fundamentals
Price
$8.37
Prev Close
$8.24
Open
$8.27
50D MA
$4.82
Beta
0.58
Avg. Volume
313,232.11
EPS (Annual)
-$14.78
P/B
-4.59
Rev/Employee
$106,563.38
Loading...
Loading...
News
all
press releases
Verrica Pharmaceuticals (NASDAQ:VRCA) CEO Jayson Rieger Purchases 94,311 Shares
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA - Get Free Report) CEO Jayson Rieger acquired 94,311 shares of the business's stock in a transaction that occurred on Tuesday, November 25th. The shares were...
MarketBeat·15d ago
News Placeholder
More News
News Placeholder
Halper Sadeh LLC Encourages Verrica Pharmaceuticals, Inc. Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Verrica Pharmaceuticals, Inc. (NASDAQ: VRCA) breached their fiduciary duties to shareholders...
Business Wire·2mo ago
News Placeholder
Verrica Pharmaceuticals Inc. (VRCA) Q2 Earnings and Revenues Beat Estimates
Verrica Pharmaceuticals (VRCA) delivered earnings and revenue surprises of +102.86% and +154.04%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago
News Placeholder
Soleno Therapeutics, Inc. (SLNO) Reports Q2 Loss, Tops Revenue Estimates
Soleno Therapeutics (SLNO) delivered earnings and revenue surprises of +83.02% and +1.58%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago
News Placeholder
Verrica Pharmaceuticals Inc. (VRCA) Reports Q1 Loss, Tops Revenue Estimates
Zacks·7mo ago
News Placeholder
Assertio (ASRT) Reports Q1 Loss, Misses Revenue Estimates
Zacks·7mo ago
News Placeholder
4D Molecular Therapeutics, Inc. (FDMT) Reports Q1 Loss, Lags Revenue Estimates
chainwire·7mo ago

Latest VRCA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.